Published in Thorax on January 07, 2014
Answer to 'COPD and IPF: it's all about regulation and balance'. Thorax (2014) 0.75
Imbalance between subpopulations of regulatory T cells in COPD. Thorax (2013) 2.13
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2013) 6.82
Pleural effusions in hematologic malignancies. Chest (2004) 3.14
Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 3.02
Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis. Am J Respir Crit Care Med (2007) 1.67
Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 1.51
Prevention of nosocomial maxillary sinusitis in the ICU: the effects of topically applied alpha-adrenergic agonists and corticosteroids. Intensive Care Med (2006) 1.48
Interferons and their application in the diseases of the lung. Chest (2003) 1.45
Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest (2005) 1.39
A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. J Transl Med (2013) 1.21
Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep (2009) 1.21
Video-assisted thoracoscopic surgery for thoracic empyema: primarily, or after fibrinolytic therapy failure? Am J Surg (2004) 1.17
Fat embolism syndrome: clinical examination is still the preferable diagnostic method. Chest (2003) 1.15
Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest (2007) 1.14
Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Cell Mol Biol (2012) 1.13
The effect of obesity on pulmonary lung function of school aged children in Greece. Pediatr Pulmonol (2009) 1.10
Warfarin in idiopathic pulmonary fibrosis: friend or foe, is it a matter of genes and heparin? Am J Respir Crit Care Med (2013) 1.09
The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res (2002) 1.08
Obstructive sleep apnea aggravates glycemic control across the continuum of glucose homeostasis. Am J Respir Crit Care Med (2010) 1.08
Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal. J Transl Med (2011) 1.07
Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur J Intern Med (2005) 1.06
A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J Infect (2009) 1.05
Acute fibrinous and organising pneumonia: a case report and review of the literature. J Med Case Rep (2009) 1.05
The pathogenesis of pulmonary fibrosis: a moving target. Eur Respir J (2012) 1.03
Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest (2006) 1.02
Smoking acutely increases plasma ghrelin concentrations. Clin Chem (2006) 1.01
γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer. Onco Targets Ther (2012) 1.00
Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role? Mediators Inflamm (2010) 0.98
Prognostic value of serum tumor markers in patients with lung cancer. Respiration (2002) 0.96
Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander? Respir Res (2006) 0.96
Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema. BMC Pulm Med (2013) 0.96
Pleural effusions in critically ill patients. Respiration (2008) 0.95
Community acquired bacterial pneumonia. Expert Opin Pharmacother (2010) 0.95
Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med (2004) 0.95
The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest (2002) 0.94
Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location. Lung Cancer (2004) 0.94
Intrapleural streptokinase for pleural infection. BMJ (2006) 0.94
HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men. Vasc Health Risk Manag (2009) 0.93
Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. J Interferon Cytokine Res (2006) 0.92
Lung cancer and interstitial lung diseases: a systematic review. Pulm Med (2012) 0.92
Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther (2006) 0.92
Effect and safety of mycophenolate mofetil or sodium in systemic sclerosis-associated interstitial lung disease: a meta-analysis. Pulm Med (2012) 0.92
Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest (2002) 0.91
Combined pulmonary fibrosis and emphysema. Expert Rev Respir Med (2013) 0.91
Stem cell therapy in pulmonary fibrosis. Curr Opin Pulm Med (2011) 0.91
Markers of glycemic control and insulin resistance in non-diabetic patients with Obstructive Sleep Apnea Hypopnea Syndrome: does adherence to CPAP treatment improve glycemic control? Sleep Med (2009) 0.91
Comorbidities and chronic obstructive pulmonary disease: is there a place for lung fibrosis? Am J Respir Crit Care Med (2013) 0.90
Pulmonary hypertension in idiopathic pulmonary fibrosis: a review. Respiration (2011) 0.90
The cost of COPD exacerbations: a university hospital--based study in Greece. Respir Med (2011) 0.89
Formoterol in the management of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2008) 0.89
Biomarkers in the Evaluation and Management of Idiopathic Pulmonary Fibrosis. Curr Top Med Chem (2016) 0.89
Sleepiness as a marker of glucose deregulation in obstructive sleep apnea. Sleep Breath (2011) 0.89
Recombinant tissue plasminogen activator in the treatment of pleural infections in adults. Respir Med (2008) 0.88
Clinical features of lung cancer in patients with connective tissue diseases: a 10-year hospital based study. Respir Med (2008) 0.88
Continuous positive airway pressure treatment in patients with sleep apnoea: does it really improve glucose metabolism? Curr Diabetes Rev (2010) 0.88
Lower respiratory tract infections caused by Haemophilus influenzae: clinical features and predictors of outcome. Med Sci Monit (2009) 0.87
Sleep apnea syndrome and diastolic blood pressure elevation during exercise. Respiration (2004) 0.87
Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients. BMC Res Notes (2012) 0.87
Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD: results of a randomized, double-blind clinical study. Can Respir J (2002) 0.87
Phase 1 trial of lipoplatin and gemcitabine as a second-line chemotherapy in patients with nonsmall cell lung carcinoma. Cancer (2008) 0.87
Stem cell treatment for chronic lung diseases. Respiration (2013) 0.87
Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis. Respir Med (2007) 0.86
Sleep-disordered breathing and quality of life of railway drivers in Greece. Chest (2008) 0.86
Prevalence and clinical characteristics of obesity hypoventilation syndrome among individuals reporting sleep-related breathing symptoms in northern Greece. Sleep Breath (2010) 0.86
Stem cell therapy in chronic obstructive pulmonary disease. Seeking the Prometheus effect. Curr Drug Targets (2013) 0.86
Current evidence for the management of paediatric parapneumonic effusions. Curr Med Res Opin (2012) 0.86
Combined pulmonary fibrosis and emphysema associated with microscopic polyangiitis. Eur Respir J (2012) 0.85
Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis. Respir Res (2009) 0.85
Serum biomarkers in interstitial lung diseases. Respir Res (2005) 0.85
Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator. Respir Res (2005) 0.85
Increased expression of epidermal growth factor receptor (EGF-R) in patients with different forms of lung fibrosis. Biomed Res Int (2013) 0.85
Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis. BMC Pulm Med (2005) 0.84
Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway. Cancer Lett (2008) 0.84
Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions. Chest (2002) 0.84
Current pharmacological treatment of pulmonary arterial hypertension. Curr Clin Pharmacol (2008) 0.83
A trial of intrapleural streptokinase. N Engl J Med (2005) 0.83
Autophagy and Bcl-2/BNIP3 death regulatory pathway in non-small cell lung carcinomas. APMIS (2012) 0.82
Determinants of continuous positive airway pressure compliance in a group of Greek patients with obstructive sleep apnea. Eur J Intern Med (2009) 0.82
Autoimmunity and chronic obstructive pulmonary disease: thinking beyond cigarette smoke. Am J Respir Crit Care Med (2012) 0.82
8-Isoprostane, a marker of oxidative stress, is increased in the expired breath condensate of patients with pulmonary sarcoidosis. Chest (2004) 0.82
Quality of life in patients with active sarcoidosis in Greece. Eur J Intern Med (2006) 0.82
Decreased apoptotic rate of alveolar macrophages of patients with idiopathic pulmonary fibrosis. Pulm Med (2012) 0.82
Predictors of obstructive sleep apnea in males with metabolic syndrome. Vasc Health Risk Manag (2010) 0.82
Continuous positive airways pressure treatment in a patient with sleep apnea-hypopnea syndrome and coexisting bipolar disorder. Psychopharmacol Bull (2008) 0.81
Steep barriers to overcome for successful application of stem cell treatment in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2013) 0.81
E-cadherin expression on fine-needle aspiration biopsies in primary lung adenocarcinomas is related to tumor differentiation and invasion. Anticancer Res (2003) 0.81
Hypofractionated/accelerated radiotherapy with cytoprotection (HypoARC) combined with vinorelbine and liposomal doxorubicin for locally advanced non-small cell lung cancer (NSCLC). Anticancer Res (2008) 0.80
Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients. Lung (2014) 0.80
Mechanisms of pleural involvement in orphan diseases. Respiration (2012) 0.80
Plasma visfatin levels in severe obstructive sleep apnea-hypopnea syndrome. Sleep Breath (2009) 0.80
Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays. Cancer Inform (2007) 0.80
Application of microarray technology in pulmonary diseases. Respir Res (2004) 0.80
Serologic evaluation in idiopathic interstitial pneumonias. Curr Opin Pulm Med (2012) 0.80
Comparative analysis of induced sputum and bronchoalveolar lavage fluid (BALF) profile in asbestos exposed workers. J Occup Med Toxicol (2011) 0.79
Triplet chemotherapy with docetaxel, gemcitabine and liposomal doxorubicin, supported with subcutaneous amifostine and hemopoietic growth factors, in advanced non-small cell lung cancer. Anticancer Res (2005) 0.79
Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea. Open Cardiovasc Med J (2011) 0.79
Reduction in cotton dust concentration does not totally eliminate respiratory health hazards: the Greek study. Toxicol Ind Health (2010) 0.79
Bronchiolitis: adopting a unifying definition and a comprehensive etiological classification. Expert Rev Respir Med (2013) 0.79
Intrapleural r-tPA in association with low-molecular heparin may cause massive hemothorax resulting in hypovolemia. Respiration (2010) 0.79
Penetration of azithromycin in experimental pleural empyema fluid. Eur J Pharmacol (2009) 0.78